A take-home allergy test called MyAllergyTest will be available beginning Oct. 1 in retail markets in the Midwest through a partnership between supplier ImmuneTech and Meijer, ImmuneTech announced Tuesday.
Drug maker Avanir Pharmaceuticals has filed suit against two generic drug makers seeking to launch versions of a drug used to treat pseudobulbar affect, which causes sudden, involuntary episodes of laughing and crying, and occurs secondary to numerous other neurological conditions.
The Alliance for Patient Care, a coalition of healthcare providers, health plans, patient advocates and others working together to protect access to care in California’s Medi-Cal (Medicaid) program, headed to Washington, D.C., to urge the Centers for Medicare and Medicaid Services and members of Congress to reject California’s proposed cut to the state’s Medi-Cal program, according to a statement issued Wednesday by the National Association of Chain Drug Stores.
The Council for Responsible Nutrition on Wednesday announced that Daniel Fabricant, director of the Division of Dietary Supplement Programs at the Food and Drug Administration, will deliver the keynote address at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry on Oct. 20 in Rancho Palos Verdes, Calif.
Patients in northern California using Kaiser Permanente’s services who received new prescriptions for statin drugs through mail-order pharmacy showed better control of their cholesterol in the first three to 15 months following the start of therapy than those who obtained them from Kaiser Permanente northern California pharmacies, according to a new study.